Vincenzi Massimo, Del Ciondolo Irene, Pasquini Elisa, Gennai Katia, Paolini Barbara
Unit of Gastroenterology and Digestive Endoscopy, San Pier Damiano Hospital, Faenza, RA, Italy.
Dietetics and Clinical Nutrition Unit, Azienda Ospedaliera Universitaria Senese, Policlinico Santa Maria alle Scotte, Siena, Italy.
J Transl Int Med. 2017 Jun 30;5(2):120-126. doi: 10.1515/jtim-2017-0004. eCollection 2017 Jun.
IBS is the most common functional disease of the low gastrointestinal tract. Recently, the interest towards a diet approach has increased, for example, a diet with low content of fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs). The aim of the present study is to evaluate the efficacy of a low FODMAP diet and a specific carbohydrate diet (SCD) conducted for 3 months on symptoms and to evaluate the deficiencies of vitamin D and folic acid in patients affected by IBS, matching the Rome IV criteria.
We evaluated 73 patients divided into 2 groups: one submitted to low FODMAP diet and one to SCD, for 3 months. Patients were assigned to one of the 2 groups randomly and blinded. All the patients filled a visual analogue scale (VAS) to evaluate the severity of symptoms and a diary to evaluate the number of days with symptoms, and this was repeated after 3 months. Final evaluation was made by a blinded investigator.
In the end, the patients with low FODMAP diet had a significant improvement in bloating and distension ( = 0.000); the group with SCD instead had a low but not a significant improvement. One way ANOVA showed comparable severity of symptoms in the 2 groups pre-diet ( = 0.215), but a difference in the same symptoms after 12 days ( = 0.000). Tukey test showed a significant improvement in the low FODMAP diet group and only a trend of improvement in the second group of SCD. The vitamin D mean value in both groups at the time of enrollment was 38 ng/mL; in the end, the mean value in the low FODMAP diet group was 32 ng/mL and in the SCD group was 22 ng/mL, with a statistically significant difference. The folic acid mean value at the time of enrollment was 18 mg/dL; in the end, the mean value in the low FODMAP diet group was 15 mg/dL and in the SCD group was 8 mg/dL, with a statistically significant difference.
Patients affected by IBS seem to have benefitted from a low FODMAP diet but not from an SCD, and a low FODMAP diet doesn't seem to cause vitamin D and folic acid deficiencies.
肠易激综合征是最常见的下消化道功能性疾病。近来,人们对饮食疗法的关注度有所提高,例如,一种可发酵低聚糖、二糖、单糖和多元醇(FODMAPs)含量低的饮食。本研究的目的是评估为期3个月的低FODMAP饮食和特定碳水化合物饮食(SCD)对症状的疗效,并评估符合罗马IV标准的肠易激综合征患者维生素D和叶酸的缺乏情况。
我们评估了73例患者,将其分为两组:一组采用低FODMAP饮食,另一组采用SCD饮食,为期3个月。患者被随机且盲法分配至两组之一。所有患者填写视觉模拟量表(VAS)以评估症状严重程度,并填写日记以评估出现症状的天数,3个月后重复此操作。最终评估由一名盲法研究者进行。
最后,采用低FODMAP饮食的患者腹胀和腹部膨胀有显著改善(=0.000);而采用SCD饮食的组改善程度较低但不显著。单因素方差分析显示两组在饮食前症状严重程度相当(=0.215),但12天后相同症状存在差异(=0.000)。Tukey检验显示低FODMAP饮食组有显著改善,而SCD组仅呈改善趋势。两组入组时维生素D的平均值为38 ng/mL;最后,低FODMAP饮食组的平均值为32 ng/mL,SCD组为22 ng/mL,差异有统计学意义。入组时叶酸的平均值为18 mg/dL;最后,低FODMAP饮食组的平均值为15 mg/dL,SCD组为8 mg/dL,差异有统计学意义。
肠易激综合征患者似乎从低FODMAP饮食中获益,而非SCD饮食,且低FODMAP饮食似乎不会导致维生素D和叶酸缺乏。